$PED

PEDEVCO CORP (PED): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PEDEVCO CORP (PED) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.5 3 ped_ex105.htm EQUITY INCENTIVE PLAN ped_ex105.htm EXHIBIT 10.5 PEDEVCO CORP. 2021 EQUITY INCENTIVE PLAN NOTICE OF PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD Capitalized but otherwise undefined terms in this Notice of Performance-Based Restricted Stock Unit Award and

Original reporting
Published Jun 23, 2026, 9:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 10:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PED
Neutral
medium confidence
Mentioned
$PED
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PEDNeutralLow
01

Why it matters

The disclosed PSU terms (unfunded, unsecured right; vesting tied to performance goals and continued service; settlement in common stock) inform how executive compensation may translate into future share issuance if performance is achieved.

02

Market read

Traders may monitor for dilution/incentive-policy signals, but the excerpt lacks quantified award size and performance targets, limiting immediate trading relevance.

03

What to watch

Without the actual PSU target number, performance goals, and any change versus prior awards, traders may overestimate the signal; the key is whether this materially increases expected share issuance.

Relevance 6/10Novelty 4/10Timing: after-hours/filing update on executive compensation terms (8-K filed 2026-06-23)

Background

The SEC 8-K (Item 5.02) includes an exhibit describing a performance-based restricted stock unit award under PEDEVCO’s 2021 Equity Incentive Plan.

Company-level read

Ticker impact

$PEDNeutralMedium confidence
Context

PEDEVCO filed an 8-K describing Item 5.02 executive/officer compensation via a performance-based PSU award under its 2021 Equity Incentive Plan.

Expected impact

Limited immediate price impact; any effect would be indirect via perceived dilution/compensation policy rather than a new operating catalyst.

Evidence & confidence

This is an SEC 8-K with compensatory arrangement details (PSU award terms) but the excerpt provides no grant size, performance targets, or quantified financial impact—so the tradable signal is likely modest.

Market effects

Minimal; compensation-plan mechanics are company-specific and not a sector-wide regulatory or operational change.

None indicated.

None indicated.

Counterpoint

The PSU structure may be largely routine and not meaningfully change dilution or incentives versus prior grants, so the market may ignore it.

Key entities

  • PEDEVCO CORP

    Subject of the SEC 8-K; disclosed performance-based PSU award terms under its equity incentive plan.

  • 2021 Equity Incentive Plan

    The governing plan referenced for the PSU award terms and definitions.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.